Global Infectious Disease Biomarker Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Description

The Infectious Disease Biomarker Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Infectious Disease Biomarker Testing size is estimated to be USD  million in 2026 from USD  million in 2020, with a change  % between 2020 and 2021. The global Infectious Disease Biomarker Testing market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
Infectious Disease Biomarker Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    PCR
    NGS
    ELISA or EIA
    IHC
    ISH
    Others

Market segment by Application, can be divided into
    Hospitals and Clinics
    Diagnostic Centers
    Academic Research Institutes
    Others

Market segment by players, this report covers
    Abacus Diagnostica
    ALPCO
    Abbott Laboratories
    Agilent Technologies
    Becton
    Dickinson and Company
    bioMérieux SA
    Bio-Rad Laboratories
    Danaher
    F. Hoffmann-La Roche
    Hologic
    PerkinElmer
    Qiagen
    Quest Diagnostics Incorporated
    Siemens Healthineers
    Thermo Fisher Scientific

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Infectious Disease Biomarker Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Infectious Disease Biomarker Testing, with revenue, gross margin and global market share of Infectious Disease Biomarker Testing from 2019 to 2021.
Chapter 3, the Infectious Disease Biomarker Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Infectious Disease Biomarker Testing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Infectious Disease Biomarker Testing research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Infectious Disease Biomarker Testing
    1.2 Classification of Infectious Disease Biomarker Testing by Type
        1.2.1 Overview: Global Infectious Disease Biomarker Testing Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Infectious Disease Biomarker Testing Revenue Market Share by Type in 2020
        1.2.3 PCR
        1.2.4 NGS
        1.2.5 ELISA or EIA
        1.2.6 IHC
        1.2.7 ISH
        1.2.8 Others
    1.3 Global Infectious Disease Biomarker Testing Market by Application
        1.3.1 Overview: Global Infectious Disease Biomarker Testing Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals and Clinics
        1.3.3 Diagnostic Centers
        1.3.4 Academic Research Institutes
        1.3.5 Others
    1.4 Global Infectious Disease Biomarker Testing Market Size & Forecast
    1.5 Global Infectious Disease Biomarker Testing Market Size and Forecast by Region
        1.5.1 Global Infectious Disease Biomarker Testing Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Infectious Disease Biomarker Testing Market Size by Region, (2016-2021)
        1.5.3 North America Infectious Disease Biomarker Testing Market Size and Prospect (2016-2026)
        1.5.4 Europe Infectious Disease Biomarker Testing Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Infectious Disease Biomarker Testing Market Size and Prospect (2016-2026)
        1.5.6 South America Infectious Disease Biomarker Testing Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Infectious Disease Biomarker Testing Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Infectious Disease Biomarker Testing Market Drivers
        1.6.2 Infectious Disease Biomarker Testing Market Restraints
        1.6.3 Infectious Disease Biomarker Testing Trends Analysis

2 Company Profiles
    2.1 Abacus Diagnostica
        2.1.1 Abacus Diagnostica Details
        2.1.2 Abacus Diagnostica Major Business
        2.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Product and Solutions
        2.1.4 Abacus Diagnostica Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Abacus Diagnostica Recent Developments and Future Plans
    2.2 ALPCO
        2.2.1 ALPCO Details
        2.2.2 ALPCO Major Business
        2.2.3 ALPCO Infectious Disease Biomarker Testing Product and Solutions
        2.2.4 ALPCO Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 ALPCO Recent Developments and Future Plans
    2.3 Abbott Laboratories
        2.3.1 Abbott Laboratories Details
        2.3.2 Abbott Laboratories Major Business
        2.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Product and Solutions
        2.3.4 Abbott Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Abbott Laboratories Recent Developments and Future Plans
    2.4 Agilent Technologies
        2.4.1 Agilent Technologies Details
        2.4.2 Agilent Technologies Major Business
        2.4.3 Agilent Technologies Infectious Disease Biomarker Testing Product and Solutions
        2.4.4 Agilent Technologies Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Agilent Technologies Recent Developments and Future Plans
    2.5 Becton
        2.5.1 Becton Details
        2.5.2 Becton Major Business
        2.5.3 Becton Infectious Disease Biomarker Testing Product and Solutions
        2.5.4 Becton Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Becton Recent Developments and Future Plans
    2.6 Dickinson and Company
        2.6.1 Dickinson and Company Details
        2.6.2 Dickinson and Company Major Business
        2.6.3 Dickinson and Company Infectious Disease Biomarker Testing Product and Solutions
        2.6.4 Dickinson and Company Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Dickinson and Company Recent Developments and Future Plans
    2.7 bioMérieux SA
        2.7.1 bioMérieux SA Details
        2.7.2 bioMérieux SA Major Business
        2.7.3 bioMérieux SA Infectious Disease Biomarker Testing Product and Solutions
        2.7.4 bioMérieux SA Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 bioMérieux SA Recent Developments and Future Plans
    2.8 Bio-Rad Laboratories
        2.8.1 Bio-Rad Laboratories Details
        2.8.2 Bio-Rad Laboratories Major Business
        2.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product and Solutions
        2.8.4 Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Bio-Rad Laboratories Recent Developments and Future Plans
    2.9 Danaher
        2.9.1 Danaher Details
        2.9.2 Danaher Major Business
        2.9.3 Danaher Infectious Disease Biomarker Testing Product and Solutions
        2.9.4 Danaher Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Danaher Recent Developments and Future Plans
    2.10 F. Hoffmann-La Roche
        2.10.1 F. Hoffmann-La Roche Details
        2.10.2 F. Hoffmann-La Roche Major Business
        2.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product and Solutions
        2.10.4 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 F. Hoffmann-La Roche Recent Developments and Future Plans
    2.11 Hologic
        2.11.1 Hologic Details
        2.11.2 Hologic Major Business
        2.11.3 Hologic Infectious Disease Biomarker Testing Product and Solutions
        2.11.4 Hologic Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Hologic Recent Developments and Future Plans
    2.12 PerkinElmer
        2.12.1 PerkinElmer Details
        2.12.2 PerkinElmer Major Business
        2.12.3 PerkinElmer Infectious Disease Biomarker Testing Product and Solutions
        2.12.4 PerkinElmer Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 PerkinElmer Recent Developments and Future Plans
    2.13 Qiagen
        2.13.1 Qiagen Details
        2.13.2 Qiagen Major Business
        2.13.3 Qiagen Infectious Disease Biomarker Testing Product and Solutions
        2.13.4 Qiagen Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Qiagen Recent Developments and Future Plans
    2.14 Quest Diagnostics Incorporated
        2.14.1 Quest Diagnostics Incorporated Details
        2.14.2 Quest Diagnostics Incorporated Major Business
        2.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product and Solutions
        2.14.4 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
    2.15 Siemens Healthineers
        2.15.1 Siemens Healthineers Details
        2.15.2 Siemens Healthineers Major Business
        2.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Product and Solutions
        2.15.4 Siemens Healthineers Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Siemens Healthineers Recent Developments and Future Plans
    2.16 Thermo Fisher Scientific
        2.16.1 Thermo Fisher Scientific Details
        2.16.2 Thermo Fisher Scientific Major Business
        2.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product and Solutions
        2.16.4 Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 Thermo Fisher Scientific Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Infectious Disease Biomarker Testing Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Infectious Disease Biomarker Testing Players Market Share
        3.2.2 Top 10 Infectious Disease Biomarker Testing Players Market Share
        3.2.3 Market Competition Trend
    3.3 Infectious Disease Biomarker Testing Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Infectious Disease Biomarker Testing Revenue and Market Share by Type (2016-2021)
    4.2 Global Infectious Disease Biomarker Testing Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Infectious Disease Biomarker Testing Revenue Market Share by Application (2016-2021)
    5.2 Infectious Disease Biomarker Testing Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Infectious Disease Biomarker Testing Revenue by Type (2016-2026)
    6.2 North America Infectious Disease Biomarker Testing Revenue by Application (2016-2026)
    6.3 North America Infectious Disease Biomarker Testing Market Size by Country
        6.3.1 North America Infectious Disease Biomarker Testing Revenue by Country (2016-2026)
        6.3.2 United States Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        6.3.3 Canada Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        6.3.4 Mexico Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Infectious Disease Biomarker Testing Revenue by Type (2016-2026)
    7.2 Europe Infectious Disease Biomarker Testing Revenue by Application (2016-2026)
    7.3 Europe Infectious Disease Biomarker Testing Market Size by Country
        7.3.1 Europe Infectious Disease Biomarker Testing Revenue by Country (2016-2026)
        7.3.2 Germany Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        7.3.3 France Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        7.3.5 Russia Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        7.3.6 Italy Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Infectious Disease Biomarker Testing Revenue by Type (2016-2026)
    8.2 Asia-Pacific Infectious Disease Biomarker Testing Revenue by Application (2016-2026)
    8.3 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region
        8.3.1 Asia-Pacific Infectious Disease Biomarker Testing Revenue by Region (2016-2026)
        8.3.2 China Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        8.3.3 Japan Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        8.3.4 South Korea Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        8.3.5 India Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        8.3.7 Australia Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Infectious Disease Biomarker Testing Revenue by Type (2016-2026)
    9.2 South America Infectious Disease Biomarker Testing Revenue by Application (2016-2026)
    9.3 South America Infectious Disease Biomarker Testing Market Size by Country
        9.3.1 South America Infectious Disease Biomarker Testing Revenue by Country (2016-2026)
        9.3.2 Brazil Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        9.3.3 Argentina Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Infectious Disease Biomarker Testing Revenue by Type (2016-2026)
    10.2 Middle East & Africa Infectious Disease Biomarker Testing Revenue by Application (2016-2026)
    10.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country
        10.3.1 Middle East & Africa Infectious Disease Biomarker Testing Revenue by Country (2016-2026)
        10.3.2 Turkey Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)
        10.3.4 UAE Infectious Disease Biomarker Testing Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Infectious Disease Biomarker Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Infectious Disease Biomarker Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Infectious Disease Biomarker Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Infectious Disease Biomarker Testing Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Infectious Disease Biomarker Testing Revenue Market Share by Region (2021-2026)
    Table 6. Abacus Diagnostica Corporate Information, Head Office, and Major Competitors
    Table 7. Abacus Diagnostica Major Business
    Table 8. Abacus Diagnostica Infectious Disease Biomarker Testing Product and Solutions
    Table 9. Abacus Diagnostica Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. ALPCO Corporate Information, Head Office, and Major Competitors
    Table 11. ALPCO Major Business
    Table 12. ALPCO Infectious Disease Biomarker Testing Product and Solutions
    Table 13. ALPCO Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
    Table 15. Abbott Laboratories Major Business
    Table 16. Abbott Laboratories Infectious Disease Biomarker Testing Product and Solutions
    Table 17. Abbott Laboratories Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Agilent Technologies Corporate Information, Head Office, and Major Competitors
    Table 19. Agilent Technologies Major Business
    Table 20. Agilent Technologies Infectious Disease Biomarker Testing Product and Solutions
    Table 21. Agilent Technologies Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Becton Corporate Information, Head Office, and Major Competitors
    Table 23. Becton Major Business
    Table 24. Becton Infectious Disease Biomarker Testing Product and Solutions
    Table 25. Becton Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Dickinson and Company Corporate Information, Head Office, and Major Competitors
    Table 27. Dickinson and Company Major Business
    Table 28. Dickinson and Company Infectious Disease Biomarker Testing Product and Solutions
    Table 29. Dickinson and Company Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. bioMérieux SA Corporate Information, Head Office, and Major Competitors
    Table 31. bioMérieux SA Major Business
    Table 32. bioMérieux SA Infectious Disease Biomarker Testing Product and Solutions
    Table 33. bioMérieux SA Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
    Table 35. Bio-Rad Laboratories Major Business
    Table 36. Bio-Rad Laboratories Infectious Disease Biomarker Testing Product and Solutions
    Table 37. Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Danaher Corporate Information, Head Office, and Major Competitors
    Table 39. Danaher Major Business
    Table 40. Danaher Infectious Disease Biomarker Testing Product and Solutions
    Table 41. Danaher Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
    Table 43. F. Hoffmann-La Roche Major Business
    Table 44. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product and Solutions
    Table 45. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Hologic Corporate Information, Head Office, and Major Competitors
    Table 47. Hologic Major Business
    Table 48. Hologic Infectious Disease Biomarker Testing Product and Solutions
    Table 49. Hologic Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. PerkinElmer Corporate Information, Head Office, and Major Competitors
    Table 51. PerkinElmer Major Business
    Table 52. PerkinElmer Infectious Disease Biomarker Testing Product and Solutions
    Table 53. PerkinElmer Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Qiagen Corporate Information, Head Office, and Major Competitors
    Table 55. Qiagen Major Business
    Table 56. Qiagen Infectious Disease Biomarker Testing Product and Solutions
    Table 57. Qiagen Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Quest Diagnostics Incorporated Corporate Information, Head Office, and Major Competitors
    Table 59. Quest Diagnostics Incorporated Major Business
    Table 60. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product and Solutions
    Table 61. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Siemens Healthineers Corporate Information, Head Office, and Major Competitors
    Table 63. Siemens Healthineers Major Business
    Table 64. Siemens Healthineers Infectious Disease Biomarker Testing Product and Solutions
    Table 65. Siemens Healthineers Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 66. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
    Table 67. Thermo Fisher Scientific Major Business
    Table 68. Thermo Fisher Scientific Infectious Disease Biomarker Testing Product and Solutions
    Table 69. Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 70. Global Infectious Disease Biomarker Testing Revenue (USD Million) by Players (2019-2021)
    Table 71. Global Infectious Disease Biomarker Testing Revenue Share by Players (2019-2021)
    Table 72. Breakdown of Infectious Disease Biomarker Testing by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 73. Infectious Disease Biomarker Testing Players Head Office, Products and Services Provided
    Table 74. Infectious Disease Biomarker Testing Mergers & Acquisitions in the Past Five Years
    Table 75. Infectious Disease Biomarker Testing New Entrants and Expansion Plans
    Table 76. Global Infectious Disease Biomarker Testing Revenue (USD Million) by Type (2016-2021)
    Table 77. Global Infectious Disease Biomarker Testing Revenue Share by Type (2016-2021)
    Table 78. Global Infectious Disease Biomarker Testing Revenue Forecast by Type (2021-2026)
    Table 79. Global Infectious Disease Biomarker Testing Revenue by Application (2016-2021)
    Table 80. Global Infectious Disease Biomarker Testing Revenue Forecast by Application (2021-2026)
    Table 81. North America Infectious Disease Biomarker Testing Revenue by Type (2016-2021) & (USD Million)
    Table 82. North America Infectious Disease Biomarker Testing Revenue by Type (2021-2026) & (USD Million)
    Table 83. North America Infectious Disease Biomarker Testing Revenue by Application (2016-2021) & (USD Million)
    Table 84. North America Infectious Disease Biomarker Testing Revenue by Application (2021-2026) & (USD Million)
    Table 85. North America Infectious Disease Biomarker Testing Revenue by Country (2016-2021) & (USD Million)
    Table 86. North America Infectious Disease Biomarker Testing Revenue by Country (2021-2026) & (USD Million)
    Table 87. Europe Infectious Disease Biomarker Testing Revenue by Type (2016-2021) & (USD Million)
    Table 88. Europe Infectious Disease Biomarker Testing Revenue by Type (2021-2026) & (USD Million)
    Table 89. Europe Infectious Disease Biomarker Testing Revenue by Application (2016-2021) & (USD Million)
    Table 90. Europe Infectious Disease Biomarker Testing Revenue by Application (2021-2026) & (USD Million)
    Table 91. Europe Infectious Disease Biomarker Testing Revenue by Country (2016-2021) & (USD Million)
    Table 92. Europe Infectious Disease Biomarker Testing Revenue by Country (2021-2026) & (USD Million)
    Table 93. Asia-Pacific Infectious Disease Biomarker Testing Revenue by Type (2016-2021) & (USD Million)
    Table 94. Asia-Pacific Infectious Disease Biomarker Testing Revenue by Type (2021-2026) & (USD Million)
    Table 95. Asia-Pacific Infectious Disease Biomarker Testing Revenue by Application (2016-2021) & (USD Million)
    Table 96. Asia-Pacific Infectious Disease Biomarker Testing Revenue by Application (2021-2026) & (USD Million)
    Table 97. Asia-Pacific Infectious Disease Biomarker Testing Revenue by Region (2016-2021) & (USD Million)
    Table 98. Asia-Pacific Infectious Disease Biomarker Testing Revenue by Region (2021-2026) & (USD Million)
    Table 99. South America Infectious Disease Biomarker Testing Revenue by Type (2016-2021) & (USD Million)
    Table 100. South America Infectious Disease Biomarker Testing Revenue by Type (2021-2026) & (USD Million)
    Table 101. South America Infectious Disease Biomarker Testing Revenue by Application (2016-2021) & (USD Million)
    Table 102. South America Infectious Disease Biomarker Testing Revenue by Application (2021-2026) & (USD Million)
    Table 103. South America Infectious Disease Biomarker Testing Revenue by Country (2016-2021) & (USD Million)
    Table 104. South America Infectious Disease Biomarker Testing Revenue by Country (2021-2026) & (USD Million)
    Table 105. Middle East & Africa Infectious Disease Biomarker Testing Revenue by Type (2016-2021) & (USD Million)
    Table 106. Middle East & Africa Infectious Disease Biomarker Testing Revenue by Type (2021-2026) & (USD Million)
    Table 107. Middle East & Africa Infectious Disease Biomarker Testing Revenue by Application (2016-2021) & (USD Million)
    Table 108. Middle East & Africa Infectious Disease Biomarker Testing Revenue by Application (2021-2026) & (USD Million)
    Table 109. Middle East & Africa Infectious Disease Biomarker Testing Revenue by Country (2016-2021) & (USD Million)
    Table 110. Middle East & Africa Infectious Disease Biomarker Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Infectious Disease Biomarker Testing Picture
    Figure 2. Global Infectious Disease Biomarker Testing Revenue Market Share by Type in 2020
    Figure 3. PCR
    Figure 4. NGS
    Figure 5. ELISA or EIA
    Figure 6. IHC
    Figure 7. ISH
    Figure 8. Others
    Figure 9. Infectious Disease Biomarker Testing Revenue Market Share by Application in 2020
    Figure 10. Hospitals and Clinics Picture
    Figure 11. Diagnostic Centers Picture
    Figure 12. Academic Research Institutes Picture
    Figure 13. Others Picture
    Figure 14. Global Infectious Disease Biomarker Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 15. Global Infectious Disease Biomarker Testing Revenue and Forecast (2016-2026) & (USD Million)
    Figure 16. Global Infectious Disease Biomarker Testing Revenue Market Share by Region (2016-2026)
    Figure 17. Global Infectious Disease Biomarker Testing Revenue Market Share by Region in 2020
    Figure 18. North America Infectious Disease Biomarker Testing Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Europe Infectious Disease Biomarker Testing Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. Asia-Pacific Infectious Disease Biomarker Testing Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 21. South America Infectious Disease Biomarker Testing Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 22. Middle East and Africa Infectious Disease Biomarker Testing Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 23. Infectious Disease Biomarker Testing Market Drivers
    Figure 24. Infectious Disease Biomarker Testing Market Restraints
    Figure 25. Infectious Disease Biomarker Testing Market Trends
    Figure 26. Abacus Diagnostica Recent Developments and Future Plans
    Figure 27. ALPCO Recent Developments and Future Plans
    Figure 28. Abbott Laboratories Recent Developments and Future Plans
    Figure 29. Agilent Technologies Recent Developments and Future Plans
    Figure 30. Becton Recent Developments and Future Plans
    Figure 31. Dickinson and Company Recent Developments and Future Plans
    Figure 32. bioMérieux SA Recent Developments and Future Plans
    Figure 33. Bio-Rad Laboratories Recent Developments and Future Plans
    Figure 34. Danaher Recent Developments and Future Plans
    Figure 35. F. Hoffmann-La Roche Recent Developments and Future Plans
    Figure 36. Hologic Recent Developments and Future Plans
    Figure 37. PerkinElmer Recent Developments and Future Plans
    Figure 38. Qiagen Recent Developments and Future Plans
    Figure 39. Quest Diagnostics Incorporated Recent Developments and Future Plans
    Figure 40. Siemens Healthineers Recent Developments and Future Plans
    Figure 41. Thermo Fisher Scientific Recent Developments and Future Plans
    Figure 42. Global Infectious Disease Biomarker Testing Revenue Share by Players in 2020
    Figure 43. Infectious Disease Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 44. Global Top 3 Players Infectious Disease Biomarker Testing Revenue Market Share in 2020
    Figure 45. Global Top 10 Players Infectious Disease Biomarker Testing Revenue Market Share in 2020
    Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 47. Global Infectious Disease Biomarker Testing Revenue Share by Type in 2020
    Figure 48. Global Infectious Disease Biomarker Testing Market Share Forecast by Type (2021-2026)
    Figure 49. Global Infectious Disease Biomarker Testing Revenue Share by Application in 2020
    Figure 50. Global Infectious Disease Biomarker Testing Market Share Forecast by Application (2021-2026)
    Figure 51. North America Infectious Disease Biomarker Testing Sales Market Share by Type (2016-2026)
    Figure 52. North America Infectious Disease Biomarker Testing Sales Market Share by Application (2016-2026)
    Figure 53. North America Infectious Disease Biomarker Testing Revenue Market Share by Country (2016-2026)
    Figure 54. United States Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Canada Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Mexico Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Europe Infectious Disease Biomarker Testing Sales Market Share by Type (2016-2026)
    Figure 58. Europe Infectious Disease Biomarker Testing Sales Market Share by Application (2016-2026)
    Figure 59. Europe Infectious Disease Biomarker Testing Revenue Market Share by Country (2016-2026)
    Figure 60. Germany Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. France Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. United Kingdom Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Russia Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Italy Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Asia-Pacific Infectious Disease Biomarker Testing Sales Market Share by Type (2016-2026)
    Figure 66. Asia-Pacific Infectious Disease Biomarker Testing Sales Market Share by Application (2016-2026)
    Figure 67. Asia-Pacific Infectious Disease Biomarker Testing Revenue Market Share by Region (2016-2026)
    Figure 68. China Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Japan Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. South Korea Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. India Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Southeast Asia Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Australia Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. South America Infectious Disease Biomarker Testing Sales Market Share by Type (2016-2026)
    Figure 75. South America Infectious Disease Biomarker Testing Sales Market Share by Application (2016-2026)
    Figure 76. South America Infectious Disease Biomarker Testing Revenue Market Share by Country (2016-2026)
    Figure 77. Brazil Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Argentina Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Middle East and Africa Infectious Disease Biomarker Testing Sales Market Share by Type (2016-2026)
    Figure 80. Middle East and Africa Infectious Disease Biomarker Testing Sales Market Share by Application (2016-2026)
    Figure 81. Middle East and Africa Infectious Disease Biomarker Testing Revenue Market Share by Country (2016-2026)
    Figure 82. Turkey Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 83. Saudi Arabia Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 84. UAE Infectious Disease Biomarker Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Companies Mentioned

Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific